Memorial Sloan Kettering will no longer allow its top executives to simultaneously sit on corporate boards of for-profit, health-related companies, including drugmakers.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,